Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acidum phosphoricum N Oligoplex
- Development stage
- Unknown
- Lead developer
- MADAUS
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Acidum phosphoricum N Oligoplex is a homeopathic complex remedy developed and marketed by Madaus (a subsidiary of Viatris). It is formulated as an oral solution (drops) containing a combination of active homeopathic ingredients: Acidum phosphoricum, Amanita muscaria, Panax ginseng, and Semecarpus anacardium. The product is traditionally used in homeopathy for the treatment of nervous exhaustion (neurasthenia) and related nervous disorders.
- Brand names
- Acidum phosphoricum N Oligoplex
- Other names
- Acidum phosphoricum N Oligoplex Liquidum
Beyond the preview
Go deeper on Acidum phosphoricum N Oligoplex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acidum phosphoricum N Oligoplex.